Keyphrases
Commercial Kits
33%
Complex Samples
33%
Coronavirus
33%
COVID-19
100%
Epidemiology
33%
Genomic Regions
33%
High Efficiency
33%
Hybrid Capture
100%
In-house Protocol
33%
Information of Interest
33%
Large RNAs
33%
Low Titre
33%
Low Viral Load
33%
Near-complete
33%
Next-generation Sequencing Technology
33%
Non-target
33%
Nucleic Acid Integrity
33%
Nucleic Acids
33%
Probe DNA
33%
Region of Interest
33%
RNA Baits
33%
RNA Virus
33%
Selective Sequencing
33%
Sequence Capture
33%
Sequence Information
33%
Sequencing Cost
33%
Sequencing Effort
33%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
33%
Targeted Gene
100%
Targeted Sequencing
33%
Viral Genome
66%
Viral Particles
33%
Virus
100%
Immunology and Microbiology
Cladistics
33%
Coronavirus
33%
DNA Hybridization
100%
DNA Probe
33%
Next Generation Sequencing
33%
RNA Probe
33%
RNA Virus
33%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Viral Load
66%
Virus
100%
Virus Genome
33%
Virus Particle
33%
Biochemistry, Genetics and Molecular Biology
Cladistics
33%
DNA Hybridization
100%
DNA Probe
33%
Genetics
33%
Genomics
33%
Next Generation Sequencing
33%
Nucleic Acid
66%
RNA Probe
33%
RNA Virus
33%
SARS Coronavirus
100%
Virus Genome
33%
Virus Load
66%
Virus Particle
33%
Medicine and Dentistry
Cohort Effect
33%
Coronavirus
33%
DNA Hybridization
100%
Health Care Cost
33%
Next Generation Sequencing
33%
Nucleic Acid
33%
Nucleic Acid Targeting
33%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Virus
100%
Virus Genome
33%
Virus Particle
33%
Virus RNA
33%